Biotest AG (WBO:BIO3)

€ 27.8 0.9 (3.35%) Market Cap: 1.37 Bil Enterprise Value: 1.86 Bil PE Ratio: 8.60 PB Ratio: 3.08 GF Score: 50/100

Q2 2024 Biotest AG Earnings Call Transcript
Aug 06, 2024

€26.3 (-1.13%)

Earnings
Q4 2022 Biotest AG Earnings Call Transcript
Mar 23, 2023

€32.8 (-0.61%)

Earnings
Q3 2022 Biotest AG Earnings Call Transcript
Nov 14, 2022

€34.4 (+0.58%)

Earnings
Q4 2021 Biotest AG Earnings Call Transcript
Mar 24, 2022

€34.8 (-1.14%)

Earnings
Q3 2021 Biotest AG Earnings Call Transcript
Nov 11, 2021

€39.1 (-0.76%)

Earnings
Grifols SA to Announce A Transformational Investment in Biotest AG Call Transcript
Sep 17, 2021
Q4 2020 Biotest AG Earnings Call Transcript
Mar 31, 2021

€30.1

Earnings
Nine Months 2020 Biotest AG Earnings Call Transcript
Nov 12, 2020

€27 (+4.65%)

Earnings
Full Year 2019 Biotest AG Earnings Call Transcript
Apr 01, 2020

€20.4 (+9.91%)

Earnings
Nine Months 2019 Biotest AG Earnings Call Transcript
Nov 14, 2019

€21.55 (+0.23%)

Earnings

Full Year 2019 Biotest AG Earnings Call Transcript

Apr 01, 2020 / 08:00AM GMT

Release Date Price: €20.4 (+9.91%)

Transcript

Operator

Ladies and gentlemen, a warm welcome to the Biotest AG Conference Call. Let me turn the floor over to Monika Buttkereit, Head of Investor Relations.

Monika Buttkereit

Biotest Aktiengesellschaft - Head of IR

Good morning, everyone, and welcome to the Biotest full year 2019 numbers. Let me hand over now to Michael Ramroth, CEO and CFO of Biotest AG.

Michael Ramroth

Biotest Aktiengesellschaft - Chairman of the Management Board, CEO & CFO

Yes. Thank you very much, Monika. And very warm welcome also from my side. Good morning to everybody. Yes, I'm actually very sorry that this year we have not the possibility to meet in person as we did in the previous years when we met in Frankfurt, looking across the Main River and talking about Biotest and the world around us.

But the world around us has changed. And therefore, we are also sticking to our social distancing policy in order to stop the spreading of the virus. Nevertheless, we are very grateful that you are taking the time to follow us today on the phone.

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.